FDA — authorised 30 May 2023
- Application: NDA217469
- Marketing authorisation holder: HARROW EYE
- Local brand name: VEVYE
- Indication: SOLUTION — OPHTHALMIC
- Status: approved
🇺🇸 Cyclosporine ophthalmic solution, 0.1% in United States
FDA authorised Cyclosporine ophthalmic solution, 0.1% on 30 May 2023
Marketing authorisation
Other Ophthalmology approved in United States
Frequently asked questions
Is Cyclosporine ophthalmic solution, 0.1% approved in United States?
Yes. FDA authorised it on 30 May 2023.
Who is the marketing authorisation holder for Cyclosporine ophthalmic solution, 0.1% in United States?
HARROW EYE holds the US marketing authorisation.